Chloroquine, a long standing treatment in rheumatic diseases, can reduce hepatic cholesterol synthesis and increase LDL receptor numbers on fibroblasts and enhances insulin secretion and sensitivity [43-45]. Here, LDLR is linked to rheumatic disorder.